LEDGERYS Trademark

Trademark Overview

On Wednesday, August 26, 2020, a trademark application was filed for LEDGERYS with the United States Patent and Trademark Office. The USPTO has given the LEDGERYS trademark a serial number of 79294814. The federal status of this trademark filing is REGISTERED as of Tuesday, June 1, 2021. This trademark is owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.. The LEDGERYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, tranquilizers, antidepressants, anxiolytics, antipsychotics; chemical products for medical use, being pharmaceuticals for treating schizophrenia; chemical pharmaceuticals for the treatment of diseases of the central nervous system; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia
ledgerys

General Information

Serial Number79294814
Word MarkLEDGERYS
Filing DateWednesday, August 26, 2020
Status700 - REGISTERED
Status DateTuesday, June 1, 2021
Registration Number6367010
Registration DateTuesday, June 1, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 16, 2021

Trademark Statements

Goods and ServicesPharmaceutical products, namely, tranquilizers, antidepressants, anxiolytics, antipsychotics; chemical products for medical use, being pharmaceuticals for treating schizophrenia; chemical pharmaceuticals for the treatment of diseases of the central nervous system; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 6, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATORIOS FARMACEUTICOS ROVI, S.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressES
Party NameLABORATORIOS FARMACEUTICOS ROVI, S.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressES
Party NameLABORATORIOS FARMACEUTICOS ROVI, S.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressES

Trademark Events

Event DateEvent Description
Friday, February 2, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, February 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 4, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 24, 2021GENERIC MADRID TRANSACTION SENT TO IB
Friday, September 24, 2021GENERIC MADRID TRANSACTION CREATED
Wednesday, September 1, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 1, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, March 24, 2021LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Monday, March 22, 2021NOTIFICATION PROCESSED BY IB
Tuesday, March 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 3, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 24, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, February 14, 2021REFUSAL PROCESSED BY IB
Wednesday, February 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 8, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 28, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 28, 2021REFUSAL PROCESSED BY MPU
Tuesday, January 12, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 11, 2021NON-FINAL ACTION WRITTEN
Sunday, December 27, 2020ASSIGNED TO EXAMINER
Friday, December 4, 2020LIMITATION OF GOODS RECEIVED FROM IB
Saturday, October 10, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, October 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, October 4, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, October 1, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

ledgerys treatment nervous system preparations diseases central schizophrenia pharmaceutical pharmaceuticals chemical